<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39382955</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-073X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Interactive journal of medical research</Title><ISOAbbreviation>Interact J Med Res</ISOAbbreviation></Journal><ArticleTitle>Changes in the Epidemiological Features of Influenza After the COVID-19 Pandemic in China, the United States, and Australia: Updated Surveillance Data for Influenza Activity.</ArticleTitle><Pagination><StartPage>e47370</StartPage><MedlinePgn>e47370</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e47370</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/47370</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There has been a global decrease in seasonal influenza activity since the onset of the COVID-19 pandemic.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to describe influenza activity during the 2021/2022 season and compare it to the trends from 2012 to 2023. We also explored the influence of social and public health prevention measures during the COVID-19 pandemic on influenza activity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We obtained influenza data from January 1, 2012, to February 5, 2023, from publicly available platforms for China, the United States, and Australia. Mitigation measures were evaluated per the stringency index, a composite index with 9 measures. A general additive model was used to assess the stringency index and the influenza positivity rate correlation, and the deviance explained was calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We used over 200,000 influenza surveillance data. Influenza activity remained low in the United States and Australia during the 2021/2022 season. However, it increased in the United States with a positive rate of 26.2% in the 49th week of 2022. During the 2021/2022 season, influenza activity significantly increased compared with the previous year in southern and northern China, with peak positivity rates of 28.1% and 35.1% in the second week of 2022, respectively. After the COVID-19 pandemic, the dominant influenza virus genotype in China was type B/Victoria, during the 2021/2022 season, and accounted for &gt;98% (24,541/24,908 in the South and 20,543/20,634 in the North) of all cases. Influenza virus type B/Yamagata was not detected in all these areas after the COVID-19 pandemic. Several measures individually significantly influence local influenza activity, except for influenza type B in Australia. When combined with all the measures, the deviance explained values for influenza A and B were 87.4% (P&lt;.05 for measures of close public transport and restrictions on international travel) and 77.6% in southern China and 83.4% (P&lt;.05 for measures of school closing and close public transport) and 81.4% in northern China, respectively. In the United States, the association was relatively stronger, with deviance-explained values of 98.6% for influenza A and 99.1% (P&lt;.05 for measures of restrictions on international travel and public information campaign) for influenza B. There were no discernible effects on influenza B activity in Australia between 2020 and 2022 due to the incredibly low positive rate of influenza B. Additionally, the deviance explained values were 95.8% (P&lt;.05 for measures of restrictions on gathering size and restrictions on international travel) for influenza A and 72.7% for influenza B.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Influenza activity has increased gradually since 2021. Mitigation measures for COVID-19 showed correlations with influenza activity, mainly driven by the early stage of the pandemic. During late 2021 and 2022, the influence of mitigation management for COVID-19 seemingly decreased gradually, as the activity of influenza increased compared to the 2020/2021 season.</AbstractText><CopyrightInformation>©Mingyue Jiang, Mengmeng Jia, Qing Wang, Yanxia Sun, Yunshao Xu, Peixi Dai, Weizhong Yang, Luzhao Feng. Originally published in the Interactive Journal of Medical Research (https://www.i-jmr.org/), 09.10.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Mingyue</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0000-3176-6066</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8175-7181</Identifier><AffiliationInfo><Affiliation>National Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-9855-4348</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2122-4009</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yunshao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3599-7907</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Peixi</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5555-8026</Identifier><AffiliationInfo><Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Weizhong</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6599-825X</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Luzhao</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5206-5995</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Interact J Med Res</MedlineTA><NlmUniqueID>101598421</NlmUniqueID><ISSNLinking>1929-073X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">seasonal variation</Keyword><Keyword MajorTopicYN="N">stringency index</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39382955</ArticleId><ArticleId IdType="pmc">PMC11499725</ArticleId><ArticleId IdType="doi">10.2196/47370</ArticleId><ArticleId IdType="pii">v13i1e47370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann G, Kawaoka Y. Seasonality of influenza and other respiratory viruses. EMBO Mol Med. 2022 Apr 07;14(4):e15352. doi: 10.15252/emmm.202115352. doi: 10.15252/emmm.202115352.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202115352</ArticleId><ArticleId IdType="doi">10.15252/emmm.202115352</ArticleId><ArticleId IdType="pmc">PMC8988196</ArticleId><ArticleId IdType="pubmed">35157360</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlhoch C, Sneiderman M, Martinuka O, Melidou A, Bundle N, Fielding J, Olsen SJ, Penttinen P, Pastore L, Pebody R, European Influenza Surveillance Network. Members of the European Influenza Surveillance Network  Spotlight influenza: The 2019/20 influenza season and the impact of COVID-19 on influenza surveillance in the WHO European Region. Euro Surveill. 2021 Oct;26(40):2100077. doi: 10.2807/1560-7917.ES.2021.26.40.2100077. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.40.2100077</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.40.2100077</ArticleId><ArticleId IdType="pmc">PMC8511754</ArticleId><ArticleId IdType="pubmed">34622760</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang J, Lv H, Lu H. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza. Biosci Trends. 2021 Jul 06;15(3):192–195. doi: 10.5582/bst.2021.01242. doi: 10.5582/bst.2021.01242.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2021.01242</ArticleId><ArticleId IdType="doi">10.5582/bst.2021.01242</ArticleId><ArticleId IdType="pubmed">34176827</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeki TM, Wentworth DE, Jernigan DB. Influenza activity in the US during the 2020-2021 season. JAMA. 2021 Jun 08;325(22):2247–2248. doi: 10.1001/jama.2021.6125.2780518</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.6125</ArticleId><ArticleId IdType="pubmed">34028492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Gómez Gómez Raquel Elizabeth, Hong K, Yum S, Jang J, Chun BC. Changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic. Int J Infect Dis. 2021 Jul;108:109–111. doi: 10.1016/j.ijid.2021.05.039. 
 
S1201-9712(21)00441-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.05.039</ArticleId><ArticleId IdType="pmc">PMC9007547</ArticleId><ArticleId IdType="pubmed">34022335</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZJ, Yu LJ, Zhang HY, Shan CX, Lu QB, Zhang XA, Ren X, Zhang CH, Wang YF, Lin SH, Xu Q, Jiang BG, Jiang T, Lv CL, Chen JJ, Gao GF, Yang WZ, Wang LP, Yang Y, Fang LQ, Liu W, Chinese Centers for Disease ControlPrevention (CDC) Etiology Surveillance Study Team of Acute Respiratory Infections  Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study. Clin Infect Dis. 2022 Aug 24;75(1):e1054–e1062. doi: 10.1093/cid/ciab942. 
 
6426178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab942</ArticleId><ArticleId IdType="pmc">PMC8767888</ArticleId><ArticleId IdType="pubmed">34788811</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A, Jasso G, Merced-Morales A, Davis CT, Jang Y, Jones J, Daly P, Gubareva L, Barnes J, Kondor R, Sessions W, Smith C, Wentworth DE, Garg S, Havers FP, Fry AM, Hall AJ, Brammer L, Silk BJ. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 23;70(29):1013–1019. doi: 10.15585/mmwr.mm7029a1. doi: 10.15585/mmwr.mm7029a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L, Zhang T, Wang Q, Xie Y, Peng Z, Zheng J, Qin Y, Zhang M, Lai S, Wang D, Feng Z, Li Z, Gao GF. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021 May 31;12(1):3249. doi: 10.1038/s41467-021-23440-1. doi: 10.1038/s41467-021-23440-1.10.1038/s41467-021-23440-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23440-1</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-23440-1</ArticleId><ArticleId IdType="pmc">PMC8167168</ArticleId><ArticleId IdType="pubmed">34059675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Lee H, Song K, Kim E, Park J, Jung J, Ahn S, Jeong EK, Park H, Kim HB. Impact of public health interventions on seasonal influenza activity during the COVID-19 outbreak in Korea. Clin Infect Dis. 2021 Jul 01;73(1):e132–e140. doi: 10.1093/cid/ciaa672. 
 
5848838</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa672</ArticleId><ArticleId IdType="pmc">PMC7314207</ArticleId><ArticleId IdType="pubmed">32472687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Du J, Li G, Chen T, Yang J, Yang J, Zhang T, Wang Q, Yang L, Lai S, Feng L, Yang W. Assessing the impact of COVID-19 interventions on influenza-like illness in Beijing and Hong Kong: an observational and modeling study. Infect Dis Poverty. 2023 Feb 16;12(1):11. doi: 10.1186/s40249-023-01061-8. 
 
10.1186/s40249-023-01061-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01061-8</ArticleId><ArticleId IdType="doi">10.1186/s40249-023-01061-8</ArticleId><ArticleId IdType="pmc">PMC9933034</ArticleId><ArticleId IdType="pubmed">36797765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Jia M, Jiang M, Liu W, Yang J, Dai P, Sun Y, Qian J, Yang W, Feng L. Seesaw effect between COVID-19 and influenza from 2020 to 2023 in World Health Organization regions: correlation analysis. JMIR Public Health Surveill. 2023 Jun 12;9:e44970. doi: 10.2196/44970. 
 
v9i1e44970</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44970</ArticleId><ArticleId IdType="pmc">PMC10263104</ArticleId><ArticleId IdType="pubmed">37191650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Jia M, Jiang M, Cao Y, Dai P, Yang J, Yang X, Xu Y, Yang W, Feng L. Increased population susceptibility to seasonal influenza during the COVID-19 pandemic in China and the United States. J Med Virol. 2023 Oct;95(10):e29186. doi: 10.1002/jmv.29186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29186</ArticleId><ArticleId IdType="pubmed">37855656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf MA, Rajaram S, English PM. How the COVID 19 pandemic will shape influenza public health initiatives: the UK experience. Hum Vaccin Immunother. 2022 Nov 30;18(5):2056399. doi: 10.1080/21645515.2022.2056399. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2056399</ArticleId><ArticleId IdType="pmc">PMC9255027</ArticleId><ArticleId IdType="pubmed">35435806</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Xiong Y, Long J, Li T, Fu X, Yang S, Tian D, Zhao Y, Qi L. Resurgence of influenza during COVID-19 in Chongqing, China: a retrospective analysis. J Med Virol. 2023 Nov;95(11):e29249. doi: 10.1002/jmv.29249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29249</ArticleId><ArticleId IdType="pubmed">38009822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, Qi J, Wu J, Zheng M. Changes in influenza activity and circulating subtypes during the COVID-19 outbreak in China. Front Med (Lausanne) 2022;9:829799. doi: 10.3389/fmed.2022.829799. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.829799</ArticleId><ArticleId IdType="pmc">PMC8980715</ArticleId><ArticleId IdType="pubmed">35391894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu S, Cowling BJ. Human influenza epidemiology. Cold Spring Harb Perspect Med. 2021 Dec 01;11(12):a038356. doi: 10.1101/cshperspect.a038356. 
 
cshperspect.a038356</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a038356</ArticleId><ArticleId IdType="pmc">PMC8634793</ArticleId><ArticleId IdType="pubmed">32988982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, Lin Y, Yang J, Fang K, Wu J, Zheng M. Global variability of influenza activity and virus subtype circulation from 2011 to 2023. BMJ Open Respir Res. 2023 Jul;10(1):e001638. doi: 10.1136/bmjresp-2023-001638. 
 
10/1/e001638</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2023-001638</ArticleId><ArticleId IdType="pmc">PMC10577751</ArticleId><ArticleId IdType="pubmed">37491131</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza transmission zones. WHO. 2018.  [2024-09-14].  
 https://www.who.int/publications/m/item/influenza_transmission_zones
.</Citation></Reference><Reference><Citation>COVID-19: stringency index. Oxford Uo.  [2024-09-14].  
 https://tinyurl.com/bd66sz5w
.</Citation></Reference><Reference><Citation>OxCGRT covid-policy-dataset. Blavatnik School of Government UoO. 2020.  [2024-10-01].  
 https://github.com/OxCGRT/covid-policy-dataset
.</Citation></Reference><Reference><Citation>Center C. Technical guidelines for national influenza surveillance. Center CNI. 2017.  [2024-09-14].  
 https://ivdc.chinacdc.cn/cnic/zyzx/jcfa/201709/P020170930331067634607.pdf
.</Citation></Reference><Reference><Citation>Influenza surveillance: purpose and methods. Prevention cfDCa.  [2023-10-13].  
 https://www.cdc.gov/fluview/overview/?CDC_AAref_Val=https://www.cdc.gov/flu/weekly/overview.htm
.</Citation></Reference><Reference><Citation>Influenza infection (flu) - CDNA national guidelines for public health units. Australian Government DoHaAC.  [2019-01-18].  
 https://www.health.gov.au/resources/publications/influenza-infection-flu-cdna-national-guidelines-for-public-health-units?language=en
.</Citation></Reference><Reference><Citation>Notice on the issuance of the ethical review methods for life sciences and medical research involving human beings. Education DoSaT.  [2024-09-14].  
 http://app.gcph.com.cn/upload/files/2023/2/2814189268.pdf
.</Citation></Reference><Reference><Citation>Coded private information or specimens use in research, guidance (2008) Services USDoHaH. 2008.  [2024-09-14].  
 https://www.hhs.gov/ohrp/regulations-and-policy/guidance/research-involving-coded-private-information/index.html
.</Citation></Reference><Reference><Citation>National Statement on Ethical Conduct in Human Research 2023. Australian Government NHMRC.  [2024-09-14].  
 https://www.nhmrc.gov.au/about-us/publications/national-statement-ethical-conduct-human-research-2023
.</Citation></Reference><Reference><Citation>Bancej C, Rahal A, Lee L, Buckrell S, Schmidt K, Bastien N. National FluWatch mid-season report, 2021-2022: sporadic influenza activity returns. Can Commun Dis Rep. 2022 Jan 26;48(1):39–45. doi: 10.14745/ccdr.v48i01a06. 
 
480106</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v48i01a06</ArticleId><ArticleId IdType="pmc">PMC8856831</ArticleId><ArticleId IdType="pubmed">35273468</ArticleId></ArticleIdList></Reference><Reference><Citation>Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol. 2021 Aug;93(8):4638–4646. doi: 10.1002/jmv.26990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26990</ArticleId><ArticleId IdType="pubmed">33792930</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Xu Y, Fan L, Huang Y, Xu M, Gao S. Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries. Proc Natl Acad Sci U S A. 2021 Aug 03;118(31):e2100201118. doi: 10.1073/pnas.2100201118. 
 
2100201118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2100201118</ArticleId><ArticleId IdType="pmc">PMC8346799</ArticleId><ArticleId IdType="pubmed">34285082</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, Yang W, Zhou X, Feng L. Influenza's plummeting during the COVID-19 pandemic: the roles of mask-wearing, mobility change, and SARS-CoV-2 interference. Engineering (Beijing) 2023 Feb;21:195–202. doi: 10.1016/j.eng.2021.12.011. 
 
S2095-8099(22)00054-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8808434</ArticleId><ArticleId IdType="pubmed">35127196</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao G, Liu W. Let's get vaccinated for both flu and COVID-19: on the World Flu Day 2021. China CDC Wkly. 2021 Oct 29;3(44):915–917. doi: 10.46234/ccdcw2021.227. 
 
ccdcw-3-44-915</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.227</ArticleId><ArticleId IdType="pmc">PMC8563337</ArticleId><ArticleId IdType="pubmed">34745691</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Yu T, Seabury SA, Dor A. Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic. Vaccine. 2022 Apr 26;40(19):2696–2704. doi: 10.1016/j.vaccine.2022.03.058. 
 
S0264-410X(22)00370-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.03.058</ArticleId><ArticleId IdType="pmc">PMC8960160</ArticleId><ArticleId IdType="pubmed">35370018</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Riccio M, Lina B, Caini S, Staadegaard L, Wiegersma S, Kynčl J, Combadière Béhazine, MacIntyre CR, Paget J. Letter to the editor: increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia. Euro Surveill. 2021 Dec;26(50):2101143. doi: 10.2807/1560-7917.ES.2021.26.50.2101143. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.50.2101143</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.50.2101143</ArticleId><ArticleId IdType="pmc">PMC8728488</ArticleId><ArticleId IdType="pubmed">34915972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Wang J, Hu L, Li B, Lu Y. Association between adult vaccine hesitancy and parental acceptance of childhood COVID-19 vaccines: a web-based survey in a northwestern region in China. Vaccines (Basel) 2021 Sep 27;9(10):1088. doi: 10.3390/vaccines9101088. 
 
vaccines9101088</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101088</ArticleId><ArticleId IdType="pmc">PMC8539638</ArticleId><ArticleId IdType="pubmed">34696196</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, Yang W, Zhou X, Feng L. The incoming influenza season—China, the United Kingdom, and the United States, 2021-2022. China CDC Wkly. 2021 Dec 03;3(49):1039–1045. doi: 10.46234/ccdcw2021.253. 
 
ccdcw-3-49-1039</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.253</ArticleId><ArticleId IdType="pmc">PMC8668409</ArticleId><ArticleId IdType="pubmed">34934512</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Zolfaghari Emameh R, Falak R. Immunopathological similarities between COVID-19 and influenza: investigating the consequences of co-infection. Microb Pathog. 2021 Mar;152:104554. doi: 10.1016/j.micpath.2020.104554. 
 
S0882-4010(20)30920-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104554</ArticleId><ArticleId IdType="pmc">PMC7607235</ArticleId><ArticleId IdType="pubmed">33157216</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W, Wang H, Sun C, Li N, Guo X, Song Q, Liang Q, Liang M, Ding X, Sun Y. The association between previous influenza vaccination and COVID-19 infection risk and severity: a systematic review and meta-analysis. Am J Prev Med. 2022 Jul;63(1):121–130. doi: 10.1016/j.amepre.2022.02.008. 
 
S0749-3797(22)00131-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8920881</ArticleId><ArticleId IdType="pubmed">35410774</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Zhong H, Xie Y, Bai T, Yan B, Sonne C. Speed up multi-pathogen surveillance. Lancet. 2023 Feb 04;401(10374):345–346. doi: 10.1016/S0140-6736(23)00134-4. 
 
S0140-6736(23)00134-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00134-4</ArticleId><ArticleId IdType="pmc">PMC9894607</ArticleId><ArticleId IdType="pubmed">36739134</ArticleId></ArticleIdList></Reference><Reference><Citation>Deji Z, Tong Y, Huang H, Zhang Z, Fang M, Crabbe MJC, Zhang X, Wang Y. Influence of environmental factors and genome diversity on cumulative COVID-19 cases in the highland region of China: comparative correlational study. Interact J Med Res. 2024 Mar 25;13:e43585. doi: 10.2196/43585. 
 
v13i1e43585</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/43585</ArticleId><ArticleId IdType="pmc">PMC10964983</ArticleId><ArticleId IdType="pubmed">38526532</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>